Fifth Third Bancorp
XLRN

Fifth Third Bancorp’s Acceleron Pharma XLRN Stock Holding History

Fifth Third Bancorp’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-59
Closed -$2K – 2386
2019
Q3 		$2K Buy
+59
New +$2.56K ﹤0.01% 2086
2019
Q1 		– Sell
-1
Closed – – 2353
2018
Q4 		$0 Buy
+1
New +$50 ﹤0.01% 2381
2017
Q2 		– Sell
-42
Closed -$1K – 2294
2017
Q1 		$1K Hold
42
– – ﹤0.01% 2073
2016
Q4 		$1K Buy
+42
New +$1.33K ﹤0.01% 2152
2014
Q4 		– Sell
-500
Closed -$15K – 2510
2014
Q3 		$15K Hold
500
– – ﹤0.01% 1877
2014
Q2 		$17K Hold
500
– – ﹤0.01% 1860
2014
Q1 		$17K Buy
+500
New +$22.6K ﹤0.01% 1845

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Fifth Third Bancorp's XLRN Position: Q4 2019 in Review

Fifth Third Bancorp sold out of Acceleron Pharma (XLRN) in Q4 2019, closing a stake of 59 shares — an estimated $2K sold.

Fifth Third Bancorp first reported a position in XLRN in Q1 2014 and held it in 7 quarters. The position peaked at $17K in Q2 2014. 183 funds tracked by Wall St. Rank hold XLRN as of Q4 2019.

  • Fifth Third Bancorp reported no remaining Acceleron Pharma position as of Q4 2019 after selling out during the quarter.
  • Fifth Third Bancorp sold 59 Acceleron Pharma shares in Q4 2019, an estimated $2K.
  • Fifth Third Bancorp first reported a position in Acceleron Pharma in Q1 2014 and held it in 7 quarters.
  • Fifth Third Bancorp's Acceleron Pharma position peaked at $17K in Q2 2014.
  • 183 funds tracked by Wall St. Rank held Acceleron Pharma as of Q4 2019.

Based on Fifth Third Bancorp's 13F filing for Q4 2019, filed 14 Feb 2020.